Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

GMP Audit Findings

GMP Compliance Risks When SOPs Are Missing for Critical Activities

Posted on By

GMP Compliance Risks When SOPs Are Missing for Critical Activities Addressing the Lack of SOPs for Critical GMP Operations Introduction to the Audit Finding 1. Why SOP Absence is a GMP Concern The absence of Standard Operating Procedures (SOPs) for critical GMP operations is one of the most serious findings in pharmaceutical audits. SOPs provide…

Read More “GMP Compliance Risks When SOPs Are Missing for Critical Activities” »

GMP Audit Findings, SOP Absence

Regulatory Impact of Missing SOPs for Deviation Management

Posted on By

Regulatory Impact of Missing SOPs for Deviation Management Ensuring Deviation Control with Documented SOPs in GMP Systems Introduction to the Audit Finding 1. Overview of the Compliance Gap Deviation management is a critical GMP requirement. When a site lacks a formal SOP to govern the handling, classification, investigation, and closure of deviations, it creates a…

Read More “Regulatory Impact of Missing SOPs for Deviation Management” »

GMP Audit Findings, SOP Absence

Compliance Risks from Missing SOPs for Vendor Qualification

Posted on By

Compliance Risks from Missing SOPs for Vendor Qualification GMP Consequences of Not Documenting Vendor Qualification Procedures Introduction to the Audit Finding 1. Criticality of Vendor Qualification Vendor qualification is a foundational requirement in the pharmaceutical supply chain. It ensures that materials, components, and services meet predefined GMP and quality criteria. 2. Absence of a Written…

Read More “Compliance Risks from Missing SOPs for Vendor Qualification” »

GMP Audit Findings, SOP Absence

Regulatory Risks of Obsolete SOPs in Circulation

Posted on By

Regulatory Risks of Obsolete SOPs in Circulation Preventing GMP Failures from Circulating Obsolete SOP Versions Introduction to the Audit Finding 1. What Are Obsolete SOPs? Obsolete SOPs refer to outdated versions of procedures that have been superseded by revised documents but remain accessible or in active use. 2. Why Is This a Problem? Using outdated…

Read More “Regulatory Risks of Obsolete SOPs in Circulation” »

GMP Audit Findings, Revision Control

Audit Risks When SOPs Lack Clear Version Identification

Posted on By

Audit Risks When SOPs Lack Clear Version Identification Ensuring SOP Version Clarity to Prevent Documentation Errors Introduction to the Audit Finding 1. Overview of the Issue When SOPs lack clear indication of the current version, users cannot confirm if they are following the latest approved procedure. This leads to regulatory and quality compliance risks. 2….

Read More “Audit Risks When SOPs Lack Clear Version Identification” »

GMP Audit Findings, Revision Control

Compliance Risks When Contract Manufacturer SOPs Are Not Integrated into Site QMS

Posted on By

Compliance Risks When Contract Manufacturer SOPs Are Not Integrated into Site QMS Integrating Third-Party SOPs into the Pharmaceutical Site QMS Introduction to the Audit Finding 1. Overview of Third-Party Manufacturing Many pharmaceutical companies rely on contract manufacturers (CMOs) to perform GMP-critical operations. However, the originating company remains fully responsible for ensuring compliance across the product…

Read More “Compliance Risks When Contract Manufacturer SOPs Are Not Integrated into Site QMS” »

GMP Audit Findings, Third-Party SOPs

Regulatory Risk When Staff Deviate from Written Procedures

Posted on By

Regulatory Risk When Staff Deviate from Written Procedures Enforcing SOP Adherence to Eliminate Process Deviations Introduction to the Audit Finding 1. Nature of the Non-Adherence Staff deviating from approved procedures is a recurring and serious GMP non-compliance issue. It undermines process control, data integrity, and product quality assurance. 2. Definition of Deviation from SOPs This…

Read More “Regulatory Risk When Staff Deviate from Written Procedures” »

GMP Audit Findings, Non-Adherence

Compliance Risks from Incomplete Execution of SOP Steps

Posted on By

Compliance Risks from Incomplete Execution of SOP Steps Ensuring Complete Execution of SOP Steps in GMP Environments Introduction to the Audit Finding 1. What Constitutes Incomplete SOP Execution? This audit finding occurs when personnel execute only selected parts of a written Standard Operating Procedure (SOP), leaving out critical or routine steps required for GMP compliance….

Read More “Compliance Risks from Incomplete Execution of SOP Steps” »

GMP Audit Findings, Non-Adherence

Regulatory Impact of Vague Terms Like ‘As Required’ in SOPs

Posted on By

Regulatory Impact of Vague Terms Like ‘As Required’ in SOPs Why Vague SOP Terms Like ‘As Required’ Pose GMP Compliance Risks Introduction to the Audit Finding 1. What Is Considered a Vague Term? Phrases like “as required,” “if needed,” “when necessary,” or “periodically” introduce ambiguity into GMP-controlled documents such as SOPs. 2. Why Is This…

Read More “Regulatory Impact of Vague Terms Like ‘As Required’ in SOPs” »

GMP Audit Findings, Poor Writing

Audit Risk from Lack of Defined Responsibilities in SOPs

Posted on By

Audit Risk from Lack of Defined Responsibilities in SOPs Clarity of Responsibility: A GMP Expectation Often Overlooked in SOPs Introduction to the Audit Finding 1. What Is the Issue? This finding refers to procedures that fail to clearly assign roles or responsibilities for execution, review, or verification of GMP-related tasks. 2. Common Examples An SOP…

Read More “Audit Risk from Lack of Defined Responsibilities in SOPs” »

GMP Audit Findings, Poor Writing

Posts pagination

1 2 … 12 Next

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme